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Purpose:  To  study  normal  lung  tissue  (NLT) complications  in magnetic  resonance  (MR)  image  based  linac
and  conventional  radiotherapy  (RT)  techniques.
Materials  and Methods:  The  Geant4  toolkit  was  used  to simulate  a 6  MV  photon  beam.  A homogenous
magnetic field  of  1.5  Tesla  (T)  was  applied  in  both  perpendicular  and  parallel  directions  relative  to the
radiation  beam.
Analysis  of the  NLT  complications  was  assessed  according  to the normal  lung tissue  complication
probability  (NTCP),  the  mean  lung  dose  (MLD),  and  percentage  of the lung  volume  receiving doses  greaterGeant4 toolkit
XCAT digital phantom
than 20  Gy  (V20),  using  a sample  set of  CT images  generated  from  a  commercially  available  4D-XCAT  digital
phantom.
Results:  The  results  show  that  the MLD  and  V20 were  lower  for MR-linac  RT.  The  largest  reduction  of  MLD
and  V20 for MR-linac  RT  configurations  were  5  Gy  and  29.3%, respectively.
Conclusion:  MR-linac  RT  may  result  in  lower  NLT  complications  when  compared  to conventional  RT.













As radiation treatments continue to develop, new technolo-
gies aim to maximize the dose delivered to the treatment volume
while minimizing the dose to the surrounding normal tissue. This
is achieved by using the dose escalation method and improving
radiation delivery systems. Implementation of image guided radia-
tion therapy is now a key component for accurate patient set-up
based on imaging systems. Daily cone-beam CT scans are per-
formed to accurately set up patients in preparation of delivering
the prescribed dose to the tumor. Margins must be added to the
tumor to ensure a proper treatment volume dose coverage. The
added margin may  result in increased irradiation of healthy tis-
sue and, consequently, higher normal tissue complications.1 There
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etic resonance imaging (MRI) during radiation therapy. The MR
uided radiotherapy improves the accuracy of such treatments due
o improved soft tissue delineation and the capability of real-time
umor tracking.2,3 The impact of this technique in radiation ther-
py has been evaluated by several investigators. Many researchers
ave investigated the effect of a magnetic field on electron and
hoton dose distributions.4–8 Some investigators have evaluated
he added challenges of magnetic fields for commonly irradiated
eometries in radiotherapy when treating early-stage non-small
ell lung cancer.9,10 It has been documented that for these systems
ose perturbations may  occur in the patient due to the Lorentz force
nd the electron-return effects (EREs).11 Currently, some stand-
lone commercial treatment planning algorithms are used to model
ose for MR-linac RT.12 The treatment planning optimization can
mprove the dose distributions over the planning target volume
PTV) and the surrounding normal tissue to compensate for dosi-
etric perturbations caused by the presence of a strong magnetic
eld. Some manufacturers have started combining MRI  and linear
erved.


























Fig. 1. Schematic configuration of the simulated linac head for 
accelerator systems into one system, allowing a real-time visual-
ization of truly adaptive radiation therapy.13
MR-linac and conventional RT techniques differ with respect to
their definition of clinical target volume (CTV) to PTV margin.14
This results in different dose distributions for the NLT. It is desired
to determine the complications in NLT based on its calculated dose
volume histogram obtained from the RT techniques mentioned
above.
The goal of the present study is to evaluate the impact of MR-
linac RT on reducing the complications to the NLT. Monte Carlo
(MC) simulation methods and the Niemierko NTCP model15 have
been used in these investigations. In these evaluations, three key
parameters that correlate to the complications of the surrounding
normal tissue receiving radiation are MLD, V20, and NTCP. These
parameters are used to compare patients treated with MR-linac
against those treated with conventional RT.
2. Materials and methods
2.1. Monte Carlo simulation
Geant4 (version 10.1.p02) was applied for all simulations in this
project. This toolkit is useful for simulating particles traversing
through matter.16
The EmLivermorePhysics C++ class was used in the program
to consider electron and photon interactions with material.17 In
Geant4, the threshold for tracking electrons and photons is defined
as a distance or an energy cut-off range.18 A 1 mm range cut-off was
selected which corresponds to an energy cut-off of 5 keV for pho-
tons, and 350 keV for electrons. This cut-off range is well covered





962a) perpendicular and (b) parallel magnetic field configurations.
ifferential equation solver, Classical Runge–Kutta, in Geant4 was
sed for calculating the trajectory of charged particles in a magnetic
eld.16
.2. Linear accelerators
A model of the Varian clinical linear accelerator (Clinac 2100,
arian Medical Systems, Palo Alto, California, USA) head was  simu-
ated according to detailed geometry from the vendor. Simulations
ere performed in two steps. First, a new scored plane was cre-
ted as a phase space file at the end of the treatment head of the
linac. Then, the phase space file acted as a source for simulat-
ng the dose distribution in the water phantom/digital phantom.
or the MR-linac configuration, we have used the same setup as
eyvanloo et al. study.20 According to this study, the treatment
ssemblies were positioned along the beam axis such that the dis-
ance from the linac target to the isocenter was  146 cm. Fig. 1 shows
he schematics of simulated geometries for both perpendicular (⊥)
nd parallel (‖) configurations. The magnet assembly consists of a
oke structure made of carbon steel material and a pair of magnetic
ole pieces made of magnetic steel.20,21 The properties of the yoke
aterial keep the magnetic field intensity at low magnetization,
hile the magnetic steel provides higher values of magnetization.22
n MR-linacs the magnetic pole pieces act to enhance the magnetic
eld strength and improve the field homogeneity in the imaging
olume.23 According to Keyvanloo’s et al.20 study, the pole-to-pole
eparation was  considered to be 60 cm with a 24 cm hole diameter
f the bore through the yoke and pole structures. The simulated
ater phantom has dimensions of 16 × 16 × 16 cm3 which were
ivided into a set of voxels with dimensions of 2 × 2 × 2 mm3 and
ocated at the isocenter.















In this study, 5 frames per respiration cycle were generated byFig. 2. Simulated geometry based on Raaijmakers et al’s study in order to test the
magnetic field effect accuracy on relative depth dose by Geant4 MC toolkit.
2.3. Monte Carlo simulation validation
Dose calculation accuracies regarding small radiation field sizes
using Geant4 have been demonstrated in our previous study.24 We
applied a 1.3 T magnetic field in MC  calculations in order to test the
accuracy of the simulated dose distributions in the presence of a
magnetic field and compared our results to Raaijmakers et al. mea-
sured data.25 In their study, dose distributions in the presence of a
1.3 T perpendicular magnetic field were measured for a 6 MV x-ray
beam. We  used similar phantom geometry which was composed





Fig. 3. 4D-CT images in 2 different respirator
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In the rest of the study, a 1.5 T magnetic field was  selected in the
eant4 simulation in order to investigate NLT complications. This
election has been based on some clinical reports which used this
trength.26–28 One simulation was  performed in the presence of a
.5 T magnetic field, perpendicular to the direction of the photon
eam, and another simulation was  performed without a magnetic
eld. The lung chemical composition data used in this study was
aken from publications from the National Institute of Standard and
echnology.29 The lung, soft tissue/tumor, and bone densities were
.3, 1.0 and 1.5 g/cm3, respectively.30
.4. The 4D extended cardiac-torso (4D-XCAT) digital phantom
The 4D-XCAT digital phantom was used as a model to pro-
ide CT images of a patient with respiratory motion. Application of
his phantom in creating CT images for radiotherapy use has been
hown previously.31he XCAT phantom. It is possible to insert different lesions into
he created CT images from the phantom.32 Spherical lesions with
iameters of 3 and 4 cm were created and located in the lower and
y phases generated by XCAT phantom.
S. Gholami et al. Reports of Practical Oncology and Radiotherapy 25 (2020) 961–968












Fig. 4. An axial view of a converted DICOM image to the voxelized geometry in Gea
Carlo  engine for conventional (a) and MR-linac for the perpendicular (b) and paralle
upper lobes of the phantom’s lungs. A combination of the lesion and
the digital phantom with the respiratory movements was utilized
to represent movable tumors inside the lung.
The CTV was defined as the volume of the inserted lesions. In
addition, for simulation of all images from the digital phantom, a
diaphragm excursion of 2 cm was considered in input data of the
phantom.
Fig. 3 shows the simulated 5-phase CT images which included
a tumor located in the lower lobe of the right lung that is based
on the XCAT phantom (breathing period: 5 s). MATLAB (7.8.0 Math
Works, Natick, MA)  software was used to convert the attenuation
values (cm−1) from the phantom to CT number (Hounsfield unit )
and finally save it as a DICOM format.33
Using methods that have been previously established,24 the
CT DICOM files were converted to the Geant4 voxelized geome-
try format.34 Further analysis included developing the program in
Geant4 toolkit to use CT data for each hit position (in X,Y,Z voxels),
using a sensitive detector method. The sensitive detector class in
Geant4 has the task of creating hits (deposits of energy) each time
a track traverses a sensitive volume and loses some energy.16
Tabulated data in the International Commission on Radiation
Units and measurements (ICRU) report # 46 were used to con-
vert Hounsfield unit values of each CT voxel to mass density and
effective atomic number.35
2.5. MC-based engine for the dose calculationsGeant4 MC-based engine was used to calculate the relative dose
distributions in the simulated patient with lung cancer for both MR-





964ig. 5. Comparative graphs of central axis relative dose between this study (with
% Error bars) and Raaijmakers’s study in the presence of the magnetic field.
he motion of the CTV defines the internal target volume (ITV) for
ach target in accordance with ICRU Report 62.36
Two different margin approaches were used for each config-
ration to define the PTV. For conventional RT, standard PTV
argins expanded the ITV by 8 mm isotropically. Meanwhile, for
he MR-linac technique, a smaller PTV using reduced margins of
pproximately 3 mm was suggested.14 The dose distributions for
he simulated lung tumor were calculated in the Geant4 engine for
onventional RT and for a MR-linac.
Fig. 4 shows an axial view of a DICOM image converted to the
oxelized geometry in Geant4 for conventional (no-B) and MR-linac
or the perpendicular and parallel configurations. For all treatment
lans, the prescribed doses were 60 Gy using 6 independent con-
ormal beams. A simple forward method was  applied to optimize












Fig. 6. Effect of magnetic fields on PDD curves and cross plane profile curves fo
relative beam weighting of each radiation beam to compensate
for dosimetric perturbations caused by the presence of a strong
magnetic field and cover the tumor with the 95% isodose line. For
simplicity, the multi-leaf collimators have not been considered in
the planning in order to reduce the computational time.
2.6. Normal lung tissue complication
The MLD,37 V20,38 and NTCP of the lung were calculated to antic-
ipate pneumonitis as a complication of NLT for each RT method.
A MATLAB script was developed to compute the NTCP values for
each method according to the formulism that was initially intro-
duced by Niemierko15. The model is well defined in the AAPM
report No.166.39
The differential dose volume histogram was directly exported
from the MC  engine and used in the NTCP calculation program.
Then, the dose values were converted into the biological equivalent










965endicular (a,c) and parallel (b,d) configurations for the field size of 3 × 3 cm2.
In the above Equation, D and nf are the total prescribed dose and
umber of fractions, respectively.  ̨ and  ̌ are the tissue-specific
arameters in the radiobiological linear-quadratic model. The EUD
s calculated according to inhomogeneous dose distribution of each










here a is a unit-less model parameter that is specific to the normal
tructure of interest. Finally, the NTCP of the organ is calculated






50 is the slope of a dose response curve of normal tissue at 50%omplication probability.40
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Table  1
For both MR-linac and conventional plans (a) Mean lung doses (MLDs) as a function of lesion diameter and its location (b) V20 for the normal lung tissue as a function of
tumor  size and its location (c) The calculated EUDs as a function of tumor sizes and its location (the diaphragm excursion is 20 mm.).
(a)
MLD (Gy)
Lesion location Lesion diameter = 3cm Lesion diameter = 4cm
MR-linac (‖) MR-linac(⊥) Conventional MR-linac(‖) MR-linac(⊥)  Conventional
RLL 12.0 14.4 17.0 16.6 18.0 21.3
LLL  10.1 12.1 14.2 14.8 16.1 19.0
RUL  6.5 7.4 8.6 8.9 9.8 10.7
LUL  9.0 10.0 11.4 12.0 13.2 14.4
(b)
V20 (%)
LesionLocation Lesion diameter = 3cm Lesion diameter = 4cm
MR-linac (‖) MR-linac(⊥) Conventional MR-linac (‖) MR-linac(⊥) Conventional
RLL 26.3 27.9 36.9 32.7 33.3 46.3
LLL  19.5 21.0 27.3 27.5 29.4 36.1
RUL  11.2 12.7 14.5 14.2 15.6 17.6
LUL  15.7 17.4 20.4 19.0 20.5 23.0
(c)
EUD (Gy)
LesionLocation Lesion diameter = 3cm Lesion diameter = 4cm
MR-linac (‖) MR-linac(⊥) Conventional MR-linac (‖) MR-linac(⊥) Conventional
RLL 11.0 12.4 15.1 15.5 16.8 20.0
LLL  9.3 10.5 12.6 14.2 15.0 18.0
RUL  6.1 7.6 8.2 8.4 9.0 9.7
LUL  8.2 9.8 10.7 9.9 10.5 11.6
Table 2
NTCPs of the lung for MR-linac (⊥ &‖) and conventional RT.
MR-linac RT(‖) MR-linac RT(⊥) Conventional RT
CASE  NTCP(%)
RLL (T.S = 3 cm,  diaph = 20 mm)  0.19% 0.28% 1.84%
RLL  (T.S = 4 cm,  diaph = 20 mm)  4.72% 7.20% 16.42%
LLL  (T.S = 3 cm, diaph = 20 mm)  0.03% 0.05% 0.50%
LLL  (T.S = 4 cm, diaph = 20 mm)  0.89% 1.90% 7.90%
RLL  (T.S = 3 cm,  diaph = 25 mm)  0.33% 1.79% 2.95%
RLL  (T.S = 4 cm,  diaph = 25 mm) 6.30% 8.40% 18.10%
LLL  (T.S = 3 cm, diaph = 25 mm)  0.13% 1.10% 1.53%
LLL  (T.S = 4 cm, diaph = 25 mm)  0.94% 1.05% 8.65%
RLL  (T.S = 3 cm,  diaph = 30 mm)  0.85% 1.65% 4.62%
RLL  (T.S = 4 cm,  diaph = 30 mm)  8.87% 10.17% 23.68%
LLL  (T.S = 3 cm, diaph = 30 mm)  0.15% 0.71% 2.94%












RUL,LUL (T.S = 3&4 cm,  diaph = 20−30 mm)  Less than 1%
RLL: Right Lower Lobe; LLL: Left Lower Lobe; T.S: Tumor size; diaph: the diaphragm
According to Eq. 4, for the endpoint of pneumonitis for normal
lung tissue, “50% complication probability (TD50)”,“ 50” , “/”
and “a” parameters were considered to be equal to 24.5 Gy; 2, 3
and 1, respectively.15,43,44
3. Results
3.1. Magnetic field simulation validation
Validation of the magnetic field calculations in our simulation
showed that dose is increased by nearly 39%, when compared to
the non-magnetic field case in the PMMA-  air interface. Ahmad
et al.12 also reported a 40% higher deposited dose at the water-
lung interface for a 1.5 T magnetic field. The difference in the results






966Less than 1% Less than 1%
rsion.RUL: Right Upper Lobe; LUL: Left Upper Lobe.
In Fig. 5, the calculated dose distributions along the central axis
n the presence of the perpendicular magnetic field are in agree-
ent within 2%/2 mm for more than 90% of the points as compared
o the data reported by Raaijmakers et al.25
Fig. 6 (a,b) shows the relative depth dose (PDD) in the absence
nd presence of a 1.5 T magnetic field for perpendicular and parallel
R-linac configurations. For a perpendicular configuration, there
s more than a 20% difference at the distal end of the PDD curve in
omparison to the applied magnetic field and non-magnetic field.
n addition, the maximum dose points in the buildup region are
hifted to shallow depths.
Fig. 6 (c,d) shows the relative cross plane profiles at three dif-
erent depths in the absence and presence of a 1.5 T magnetic field
f perpendicular and parallel MR-linac configurations for a field
ize of 3 × 3 cm2. In the parallel configuration, the profiles remain
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pendicular configuration due to the imposed force of magnetic field
on secondary electrons.
3.2. MLD, V20, EUD and NTCP for MR-linac and conventional RT
Tables 1 (a), (b), and (c) present a comparison between the tumor
size, its location, MLDs, V20 s, and EUDs for both MR-linac and
conventional radiation therapy techniques, respectively.
Furthermore, MLD, V20, and EUD were lower for MR-linac RT,
especially for the parallel configuration. The largest reduction of
MLD, V20, and EUD with MR-linac RT were 5 Gy, 29.3% and 4.1 Gy,
respectively.
Table 2 shows that lung NTCPs are lower in the MR-linac (⊥ &‖)
RT in comparison with the conventional RT. Here, too, this reduc-
tion is higher for parallel configuration (up to 15%) and the tumors
that were in the lower lobe of the lung and near the diaphragm.
For the tumors located in the upper lobes, where the tumor
motion was small, NTCP values of the lung were insignificant in
both RT techniques (< 1%).
4. Discussion
In the first part of this study we simulated the MR-Linac irradia-
tion in the presence of a 1.3 T magnetic field in order to validate
the accuracy of the simulation in an inhomogeneous phantom
and compared it to the published measured data.25 Then a 1.5 T
magnetic field was applied in MC  simulation in both parallel and
perpendicular directions. We  have considered this strength due to
some clinical reports in this strength. Ahmed et al.12 and Raaij-
makers et al.25 reported around a 40% higher deposited dose at the
water-lung interface for a 1.5 T and 1.3 T magnetic field. The differ-
ence in the results of these two magnetic field strengths (1.3 and
1.5 T) seems negligible. Finally, calculated NTCP values in MR-Linac
and conventional radiotherapy were compared with each other.
The results from PDD profiles show that in the perpendicular
geometry, the dose profiles shift asymmetrically away from the
beam axis at all depths in the presence of the magnetic field. A
similar study has shown the effect on the dose profile as reported
by Raaymakers et al.45 They show that the dose deposition changes
asymmetrically in the direction perpendicular to the magnetic field
which is seen in our profiles as well. For PDD curves, there are two
differences: one in the buildup region and the other at the distal
part of the PDD curve. Depth of the maximum dose was found shal-
lower (∼3−4 mm)  in the presence of a magnetic field. The reason
is that electrons travel curved pathways and deposit their energy
at relatively shorter distances from the surface in a magnetic field.
The increase of relative dose at the distal part of the PDD curve is
due to ERE. Such an effect on dose profiles have also been reported
by Ahmad et al.12 and Raaijmakers et al.25 In the parallel geometry
the beam profiles (and penumbras) do not change as compared to
non-magnetic field case for all depths, which is in agreement with
Kirkby et al., using the EGSnrc simulation code.28
Due to EREs an increase in the dose was found to occur at the
distal end of lung tissue. However, the increase of this dose is
insignificant when considering the negligible effect it has on the
clinically relevant parameters, such as EUD, V20, MLD, and NTCP
values. The increase of dose may  be due to the EREs at the air tissue
interfaces, such as the chest wall and lung or the mediastinum and
lung.
The reduction in lung NTCP in the MR-linac technique is due
to reducing the CTV-to-PTV margin rather than more uniform dose
distributions and, as the results showed, the magnetic field tends to
make some hot and cold sub regions to the irradiated volume. How-
ever, in general, it can be said that using the MR-linac configuration
is reasonable and can reduce NLT complications.
967Reports of Practical Oncology and Radiotherapy 25 (2020) 961–968
. Conclusion
In this study, we investigated the benefits of MR-linac RT versus
onventional RT in a simulation study. Despite the disturbance in
ose distributions (cold and hot points) in the presence of the mag-
etic field, the MR-linac RT can lead to lower complications in NLT
ompared to the conventional RT.
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